RSI Overbought Stocks
HUM is RSI overbought, meaning strong buying pressure may lead to a short-term consolidation or pullback.
HUMANA INC (HUM) Stock Price & Overview
NYSE:HUM • US4448591028
Current stock price
233.63 USD
-2.81 (-1.19%)
At close:
232 USD
-1.63 (-0.7%)
After Hours:
The current stock price of HUM is 233.63 USD. Today HUM is down by -1.19%. In the past month the price increased by 31.38%. In the past year, price decreased by -9.61%.
HUM Key Statistics
52-Week Range163.11 - 315.348
Current HUM stock price positioned within its 52-week range.
1-Month Range177.54 - 246.82
Current HUM stock price positioned within its 1-month range.
- Market Cap
- 28.047B
- P/E
- 14.73
- Fwd P/E
- 15.40
- EPS (TTM)
- 15.86
- Dividend Yield
- 1.50%
HUM Stock Performance
Today
-1.19%
1 Week
+8.55%
1 Month
+31.38%
3 Months
+19.69%
Longer-term
6 Months -16.02%
1 Year -9.61%
2 Years -34.76%
3 Years -53.45%
5 Years -46.62%
10 Years +35.43%
HUM Stock Chart
HUM Stock Screens
HUM currently appears in the following ChartMill screener lists.
HUM Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to HUM. When comparing the yearly performance of all stocks, HUM turns out to be only a medium performer in the overall market: it outperformed 49.02% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
HUM Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to HUM. While HUM is still in line with the averages on profitability rating, there are concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
HUM Earnings
On April 29, 2026 HUM reported an EPS of 10.31 and a revenue of 39.65B. The company beat EPS expectations (0.21% surprise) and missed revenue expectations (-0.27% surprise).
Next Earnings DateJul 29, 2026
Last Earnings DateApr 29, 2026
PeriodQ1 / 2026
EPS Reported$10.31
Revenue Reported39.648B
EPS Surprise 0.21%
Revenue Surprise -0.27%
HUM Forecast & Estimates
33 analysts have analysed HUM and the average price target is 220.62 USD. This implies a price decrease of -5.57% is expected in the next year compared to the current price of 233.63.
For the next year, analysts expect an EPS growth of -45.51% and a revenue growth 25.31% for HUM
Analysts
Analysts68.48
Price Target220.62 (-5.57%)
EPS Next Y-45.51%
Revenue Next Year25.31%
HUM Index Membership
HUM is currently included in the following stock indexes tracked on ChartMill.
HUM Financial Highlights
Over the last trailing twelve months HUM reported a non-GAAP Earnings per Share(EPS) of 15.86. The EPS decreased by -22.78% compared to the year before.
Income Statements
Revenue(TTM)129.66B
Net Income(TTM)1.19B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.92% | ||
| ROA | 2.43% | ||
| ROE | 6.73% | ||
| Debt/Equity | 0.7 |
Chartmill High Growth Momentum
EPS Q2Q%-10.97%
Sales Q2Q%23.47%
EPS 1Y (TTM)-22.78%
Revenue 1Y (TTM)10.11%
HUM Ownership
Ownership
Inst Owners104.3%
Shares120.05M
Float119.81M
Ins Owners0.15%
Short Float %4.53%
Short Ratio3.14
HUM Industry Overview
HUM operates in the Managed Health Care sub-industry within the Health Care sector. This group contains 9 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
40/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
71/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
99%
Outperformed 99% of sub-industries
3 Month Rank
76%
Outperformed 76% of sub-industries
6 Month Rank
67%
Outperformed 67% of sub-industries
Industry Fundamentals & Breadth
- Members
- 9
- New Highs
- 0%
- New Lows
- 0%
- Average ROE
- 11.2%
- Average Profit Margin
- 2.7%
- Average Operating Margin
- 4.2%
- Average P/E
- 22.3
- Average Fwd P/E
- 17.3
- Average Debt/Equity
- 0.7
HUM Latest News, Press Relases and Analysis
4 days ago - By: Chartmill
HUM Competitors/Peers
The largest stocks on the US markets in the "Managed Health Care" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 18.39 | 334.734B | ||
| ELV | ELEVANCE HEALTH INC | 12.61 | 81.863B | ||
| CNC | CENTENE CORP | 13.29 | 26.231B | ||
| MOH | MOLINA HEALTHCARE INC | 21.18 | 10.038B | ||
| HQY | HEALTHEQUITY INC | 17.65 | 6.961B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | 53.68 | 4.139B | ||
| PGNY | PROGYNY INC | 13.83 | 1.457B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.422B |
Related stock screener links
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HUM
Company Profile
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Company Info
IPO: 1971-05-18
HUMANA INC
101 E. Main Street
Louisville KENTUCKY 40202 US
CEO: Bruce D. Broussard
Employees: 67060
Phone: 13026587581
HUMANA INC / HUM FAQ
What does HUM do?
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
What is the current price of HUM stock?
The current stock price of HUM is 233.63 USD. The price decreased by -1.19% in the last trading session.
Does HUMANA INC pay dividends?
HUMANA INC (HUM) has a dividend yield of 1.5%. The yearly dividend amount is currently 3.57.
What is the ChartMill technical and fundamental rating of HUM stock?
HUM has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the growth outlook for HUMANA INC?
The Revenue of HUMANA INC (HUM) is expected to grow by 25.31% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the upcoming earnings date for HUMANA INC?
HUMANA INC (HUM) will report earnings on 2026-07-29, before the market open.
What is the Short Interest ratio of HUMANA INC (HUM) stock?
The outstanding short interest for HUMANA INC (HUM) is 4.53% of its float.